Drug-Induced Cough
- PMID: 32228014
- PMCID: PMC8604055
- DOI: 10.33549/physiolres.934406
Drug-Induced Cough
Abstract
Since the recognition of angiotensin-converting enzyme inhibitors (ACEIs)-induced cough, drug has been considered as a potential cause of chronic cough. This review presents recent knowledge on drug-induced coughs in patients with chronic cough. The focus is placed on ACEIs, for which there are a multitude of studies documenting their associations with cough. Additional drugs are discussed for which there are reports of cough as a side effect of treatment, and the potential mechanisms of these effects are discussed.
Conflict of interest statement
There is no conflict of interest.
Figures


References
-
- AHREN B, JOHNSON SL, STEWART M, CIRKEL DT, YANG F, PERRY C, FEINGLOS MN HARMONY STUDY GROUP. HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin. Diabetes Care. 2014;37:2141–2148. doi: 10.2337/dc14-0024. - DOI - PubMed
-
- ALHARBI FF, KHOLOD AAV, SOUVEREIN PC, MEYBOOM RH, DE GROOT MCH, DE BOER A, KLUNGEL OH. The impact of age and sex on the reporting of cough and angioedema with renin-angiotensin system inhibitors, a case/noncase study in VigiBase. Fundam Clin Pharmacol. 2017;31:676–684. doi: 10.1111/fcp.12313. - DOI - PubMed
-
- ARJONA FERREIRA JC, CORRY D, MOGENSEN CE, SLOAN L, XU L, GOLM GT, GONZALEZ EJ, DAVIES MJ, KAUFMAN KD, GOLDSTEIN BJ. Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trial. Am J Kidney Dis. 2013;61:579–587. doi: 10.1053/j.ajkd.2012.11.043. - DOI - PubMed